QuiVad

Home / Funds / GSA Capital Partners LLP

GSA Capital Partners LLP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSinceFiling
Valneva SEFrance1.21%July 21, 2026AMF
Oncopeptides ABSweden1.19%September 22, 2026
Tobii ABSweden1.19%September 10, 2026
Tessellis SPAItaly1.18%August 24, 2026
Powercell Sweden AB (publ)Sweden1.00%September 11, 2026
RaySearch Laboratories AB (publ)Sweden1.00%September 14, 2026
Hexagon CompositesNorway0.99%August 24, 2026
Hilbert Group AB (publ)Sweden0.91%September 21, 2026
OssDsign ABSweden0.81%June 1, 2026
2020 BulkersNorway0.71%September 22, 2026
Trevi - Finanziaria Industriale SPAItaly0.61%August 24, 2026
BFF Bank SPAItaly0.60%September 8, 2026
Hansa Biopharma ABSweden0.60%September 9, 2026
Solutions 30 SEFrance0.60%September 11, 2026
Elliptic Laboratories ASANorway0.51%August 26, 2026
Smart Eye Aktiebolag (publ)Sweden0.51%August 27, 2026
EuroAPIFrance0.50%September 14, 2026
NSI N.V.Netherlands0.50%September 18, 2026
Nobia ABSweden0.50%June 12, 2026
Tubacex, S.A.Spain0.50%July 10, 2026

Follow by RSS

Get the moves on GSA Capital Partners LLP by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

4501 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publicationFiling
March 22, 2013FuturenFrance0.50%July 15, 2013

The AMF column opens the filing the fund itself lodged, on the regulator own site.

Download 4501 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

The funds short on the same companies

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, GSA Capital Partners LLP, data as at September 22, 2026, https://www.quivad.com/detenteur/gsa-capital-partners-llp?page=91